MarkL.SanzMD

Cardiology • Missoula, MT

Adult Congenital Heart Disease, Interventional Cardiology

Physician

Join to view full profile

Dr. Sanz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Sanz's full profile

Already have an account?

Office
3122 Martinwood Rd
Missoula, MT 59802
Is this information wrong?

Education & Training

University of Michigan Health SystemFellowship, Cardiovascular Disease, 1985 - 1988
HCA HealthONEResidency, Internal Medicine, 1983 - 1985
University of ColoradoResidency, Internal Medicine, 1980 - 1982
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1980

Certifications & Licensure

MT State Medical License 1988 - 2025
OR State Medical License 2015 - 2019
WA State Medical License 2015 - 2018
ID State Medical License 2008 - 2014
MI State Medical License 1985 - 1989
CO State Medical License 1981 - 1989
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Fellow (FACC) American College of Cardiology

Clinical Trials

Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (The COAPT Trial) and COAPT CAS Start of enrollment: 2012 Aug 01
Active, not recruiting
Not Applicable

Publications & Presentations

PubMed

1 citations
A method to estimate the mean lifetime survival increase of statin therapy.
Shu-Ching Chang, Mansen Wang, James G Beckerman, Mark L. Sanz, Tyler J Gluckman, Gary L. Grunkemeier> ;Future Cardiology. 2016 Aug 19
145 citations
5-Year Results of a Randomized Comparison of XIENCE V Everolimus-Eluting and TAXUS Paclitaxel-Eluting Stents: Final Results From the SPIRIT III Trial (Clinical Evaluat...
Hemal Gada, Ajay J. Kirtane, William G. Newman, Mark Sanz, James B. Hermiller, Kenneth W. Mahaffey, Donald E. Cutlip, Krishnankutty Sudhir, Liming Hou, Kai Koo, Gregg ...> ;JACC. Cardiovascular Interventions. 2013 Dec 1
50 citations
ACCF 2012 Health Policy Statement on Patient-Centered Care in Cardiovascular Medicine: A Report of the American College of Cardiology Foundation Clinical Quality Commi...
Mary Norine Walsh, Alfred A. Bove, Russell R. Cross, Keith C. Ferdinand, Daniel E. Forman, Andrew M. Freeman, Suzanne Hughes, Elizabeth Klodas, Michelle Koplan, Willia...> ;Journal of the American College of Cardiology. 2012 Jun 5
ACCF/AHA 2011 Health Policy Statement on Therapeutic Interchange and Substitution A Report of the American College of Cardiology Foundation Clinical Quality Committee.
Holmes, D.R., Becker, J.A., Granger, C.B., Limacher, M.C., Page, R.L., Sila, C., Drozda, J.P., Cacchione, J.G., Erb, B.D., Harrington, R.A., Kennett, J.D., Krumholz, H...> ;J Am Coll Cardiol. 2011 Sep 13
7 citations
An experimental method for the percutaneous induction of a posterolateral infarct and functional ischemic mitral regurgitation.
Thomas M. Joudinaud, Corrine L. Kegel, Alan A. Gabster, Mark L Sanz, Alistair MacDonald, Dan Propp, Edward Callaghan, Patricia A. Weber, Ulrik Hvass, Carlos M.G. Duran> ;The Journal of Heart Valve Disease. 2005 Jul 1
Join now to see all

Press Mentions

ACCF 2012 Health Policy Statement on Patient-Centered Care in Cardiovascular Medicine A Report of the American College of Cardiology Foundation Clinical Quality CommitteeMarch 1st, 2019
Structured Reporting: The Cardiologist’s View on the Value of Quality Data CollectionMay 26th, 2016
Journal of the American College of Cardiology Vol. 63, No. 7, 2014 Â© 2014 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00September 20th, 2012